{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-102321","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2024-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.830581+00:00","generated_at":"2026-05-31T06:50:26.351567+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MiNK Therapeutics receives Nasdaq delisting notice for failing to meet $1.00 bid price rule","bullets":["Nasdaq notified MiNK on Aug 27, 2024 that it failed to regain compliance with the $1.00 minimum bid price within the 180-day grace period ending Aug 26, 2024.","Common stock (INKT) is now subject to potential delisting from Nasdaq.","MiNK intends to request a hearing before the Nasdaq Hearings Panel, which will stay any delisting action pending the process.","No assurance that the Panel will allow continued listing or that compliance can be demonstrated within any extension granted."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-102321","json":"https://secwatch.observer/filing/0000950170-24-102321.json","markdown":"https://secwatch.observer/filing/0000950170-24-102321.md","text":"https://secwatch.observer/filing/0000950170-24-102321.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024102321/0000950170-24-102321-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024102321/inkt-20240827.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:50:26.351567+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}